Ronald K. Lloyd
Net Worth
Last updated:
What is Ronald K. Lloyd net worth?
The estimated net worth of Mr. Ronald K. Lloyd is at least $3,562,280 as of 8 Mar 2022. He has received compensation worth at least $3,562,280 in Aziyo Biologics, Inc..
What is the salary of Ronald K. Lloyd?
Mr. Ronald K. Lloyd salary is $890,570 per year as Chief Executive Officer, Pres & Director in Aziyo Biologics, Inc..
How old is Ronald K. Lloyd?
Mr. Ronald K. Lloyd is 64 years old, born in 1961.
What stocks does Ronald K. Lloyd currently own?
As insider, Mr. Ronald K. Lloyd owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Aziyo Biologics, Inc. (AZYO) | Chief Executive Officer, Pres & Director | 23,151 | $0 | $0 |
What does Aziyo Biologics, Inc. do?
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Ronald K. Lloyd insider trading
Aziyo Biologics key executives
Aziyo Biologics, Inc. executives and other stock owners filed with the SEC:
- Dr. Darryl Roberts Ph.D. (64) Executive Vice President of Operations & Product Devel.
- Dr. Jerome Riebman FACC, M.A., M.D. (71) Chief Medical Officer
- Mr. Ronald K. Lloyd (64) Chief Executive Officer, Pres & Director